The prevalence, maintenance, and relevance of g protein-coupled receptor oligomerization

Molecular Pharmacology

Volumn 84, Issue 1, 2013, Pages 158-169

  Milligan, Graeme ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; G PROTEIN COUPLED RECEPTOR; MONOMER; OLIGOMER; RHODOPSIN; SEROTONIN 2A AGONIST; SEROTONIN 2A RECEPTOR;

BEHAVIOR; GENETIC TRANSFECTION; HUMAN; LIGAND BINDING; NONHUMAN; OLIGOMERIZATION; PREVALENCE; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN QUATERNARY STRUCTURE; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; PREVALENCE; PROTEIN MULTIMERIZATION; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84879121186     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.113.084780     Document Type: Review

References (135)

1. Albizu L, Cottet M, Kralikova M, Stoev S, Seyer R, Brabet I, Roux T, Bazin H, Bourrier E, and Lamarque L et al. (2010) Time-resolved FRET between GPCR ligands reveals oligomers in native tissues. Nat Chem Biol 6:587-594.
2. Alvarez-Curto E, Pediani JD, and Milligan G (2010a) Applications of fluorescence and bioluminescence resonance energy transfer to drug discovery at G protein coupled receptors. Anal Bioanal Chem 398:167-180.
3. Alvarez-Curto E, Ward RJ, Pediani JD, and Milligan G (2010b) Ligand regulation of the quaternary organization of cell surface M3 muscarinic acetylcholine receptors analyzed by fluorescence resonance energy transfer (FRET) imaging and homogeneous time-resolved FRET. J Biol Chem 285:23318-23330.
4. Ambrosio M, Zürn A, and Lohse MJ (2011) Sensing G protein-coupled receptor activation. Neuropharmacology 60:45-51.
5. Angers S, Salahpour A, Joly E, Hilairet S, Chelsky D, Dennis M, and Bouvier M (2000) Detection of beta 2-Adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc Natl Acad Sci USA 97: 3684-3689.
6. Appelbe S and Milligan G (2009) Chapter 10. Hetero-oligomerization of chemokine receptors. Methods Enzymol 461:207-225.
7. Arcemisbéhère L, Sen T, Boudier L, Balestre MN, Gaibelet G, Detouillon E, Orcel H, Mendre C, Rahmeh R, and Granier S et al. (2010) Leukotriene BLT2 receptor monomers activate the G(i2) GTP-binding protein more efficiently than dimers. J Biol Chem 285:6337-6347.
8. Bayburt TH, Vishnivetskiy SA, McLean MA, Morizumi T, Huang CC, Tesmer JJ, Ernst OP, Sligar SG, and Gurevich VV (2011) Monomeric rhodopsin is sufficient for normal rhodopsin kinase (GRK1) phosphorylation and arrestin-1 binding. J Biol Chem 286:1420-1428
9. Beermann S, Seifert R, and Neumann D (2012) Commercially available antibodies against human and murine histamine H-receptor lack specificity. Naunyn Schmiedebergs Arch Pharmacol 385:125-135.
10. Benneyworth MA, Xiang Z, Smith RL, Garcia EE, Conn PJ, and Sanders-Bush E (2007) A selective positive allosteric modulator of metabotropic glutamate receptor subtype 2 blocks a hallucinogenic drug model of psychosis. Mol Pharmacol 72:477-484.
11. Berger AC and Whistler JL (2010) How to design an opioid drug that causes reduced tolerance and dependence. Ann Neurol 67:559-569.
12. Brea J, Castro M, Giraldo J, López-Giménez JF, Padín JF, Quintián F, Cadavid MI, Vilaró MT, Mengod G, and Berg KA et al. (2009) Evidence for distinct antagonistrevealed functional states of 5-hydroxytryptamine(2A) receptor homodimers. Mol Pharmacol 75:1380-1391.
13. Bushlin I, Gupta A, Stockton SD, Jr., Miller LK, and Devi LA (2012) Dimerization with cannabinoid receptors allosterically modulates delta opioid receptor activity during neuropathic pain. PLoS ONE 7:e49789.
14. Calebiro D, Rieken F, Wagner J, Sungkaworn T, Zabel U, Borzi A, Cocucci E, Zürn A, and Lohse MJ (2013) Single-molecule analysis of fluorescently labeled G-proteincoupled receptors reveals complexes with distinct dynamics and organization. Proc Natl Acad Sci USA 110:743-748
15. Canals M, Lopez-Gimenez JF, and Milligan G (2009) Cell surface delivery and structural re-organization by pharmacological chaperones of an oligomerizationdefective alpha(1b)-Adrenoceptor mutant demonstrates membrane targeting of GPCR oligomers. Biochem J 417:161-172.
16. Canals M and Milligan G (2008) Constitutive activity of the cannabinoid CB1 receptor regulates the function of co-expressed Mu opioid receptors. J Biol Chem 283: 11424-11434.
17. Casadó V, Cortés A, Mallol J, Pérez-Capote K, Ferré S, Lluis C, Franco R, and Canela EI (2009) GPCR homomers and heteromers: a better choice as targets for drug development than GPCR monomers? Pharmacol Ther 124:248-257.
18. Casciari D, Dell'Orco D, and Fanelli F (2008) Homodimerization of neurotensin 1 receptor involves helices 1, 2, and 4: insights from quaternary structure predictions and dimerization free energy estimations. J Chem Inf Model 48:1669-1678
19. Chabre M, Cone R, and Saibil H (2003) Biophysics: is rhodopsin dimeric in native retinal rods? Nature 426:30-31, discussion 31.
20. Chandrashekar J, Hoon MA, Ryba NJ, and Zuker CS (2006) The receptors and cells for mammalian taste. Nature 444:288-294.
21. Costantino CM, Gomes I, Stockton SD, Lim MP, and Devi LA (2012) Opioid receptor heteromers in analgesia. Expert Rev Mol Med 14:e9.
22. Cottet M, Albizu L, Comps-Agrar L, Trinquet E, Pin JP, Mouillac B, and Durroux T (2011) Time resolved FRET strategy with fluorescent ligands to analyze receptor interactions in native tissues: application to GPCR oligomerization. Methods Mol Biol 746:373-387.
23. Cunningham MR, McIntosh KA, Pediani JD, Robben J, Cooke AE, Nilsson M, Gould GW, Mundell S, Milligan G, and Plevin R (2012) Novel role for proteinase-Activated receptor 2 (PAR2) in membrane trafficking of proteinase-Activated receptor 4 (PAR4). J Biol Chem 287:16656-16669.
24. de la Fuente M, Noble DN, Verma S, and Nieman MT (2012) Mapping human protease-Activated receptor 4 (PAR4) homodimer interface to transmembrane helix 4. J Biol Chem 287:10414-10423.
25. Del Burgo LS and Milligan G (2010) Heterodimerisation of G protein-coupled receptors: implications for drug design and ligand screening. Expert Opin Drug Discov 5:461-474.
26. Delille HK, Becker JM, Burkhardt S, Bleher B, Terstappen GC, Schmidt M, Meyer AH, Unger L,Marek GJ, andMezlerM(2012) Heterocomplex formation of 5-HT2A-mGlu2 and its relevance for cellular signaling cascades. Neuropharmacology 62:2184-2191.
27. Dorsch S, Klotz KN, Engelhardt S, Lohse MJ, and Bünemann M (2009) Analysis of receptor oligomerization by FRAP microscopy. Nat Methods 6:225-230.
28. Doumazane E, Scholler P, Zwier JM, Trinquet E, Rondard P, and Pin JP (2011) A new approach to analyze cell surface protein complexes reveals specific heterodimeric metabotropic glutamate receptors. FASEB J 25:66-77.
29. Ferré S, Lluis C, Lanciego JL, and Franco R (2010) Prime time for G-protein-coupled receptor heteromers as therapeutic targets for CNS disorders: the dopamine D-D receptor heteromer. CNS Neurol Disord Drug Targets 9:596-600.
30. Filip M, Zaniewska M, Frankowska M, Wydra K, and Fuxe K (2012) The importance of the adenosine A(2A) receptor-dopamine D(2) receptor interaction in drug addiction. Curr Med Chem 19:317-355.
31. Fonseca JM and Lambert NA (2009) Instability of a class a G protein-coupled receptor oligomer interface. Mol Pharmacol 75:1296-1299.
32. Fotiadis D, Liang Y, Filipek S, Saperstein DA, Engel A, and Palczewski K (2003) Atomic-force microscopy: Rhodopsin dimers in native disc membranes. Nature 421: 127-128
33. Fribourg M, Moreno JL, Holloway T, Provasi D, Baki L, Mahajan R, Park G, Adney SK, Hatcher C, and Eltit JM et al. (2011) Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs. Cell 147:1011-1023.
34. Fung JJ, Deupi X, Pardo L, Yao XJ, Velez-Ruiz GA, Devree BT, Sunahara RK, and Kobilka BK (2009) Ligand-regulated oligomerization of beta(2)-Adrenoceptors in a model lipid bilayer. EMBO J 28:3315-3328
35. Fuxe K, Borroto-Escuela DO, Marcellino D, Romero-Fernandez W, Frankowska M, Guidolin D, Filip M, Ferraro L, Woods AS, and Tarakanov A et al. (2012) GPCR heteromers and their allosteric receptor-receptor interactions. Curr Med Chem 19: 356-363.
36. Ganguly S, Clayton AH, and Chattopadhyay A (2011) Organization of higher-order oligomers of the serotonin(A) receptor explored utilizing homo-FRET in live cells. Biophys J 100:361-368
37. Geng Y, Xiong D, Mosyak L, Malito DL, Kniazeff J, Chen Y, Burmakina S, Quick M, Bush M, and Javitch JA et al. (2012) Structure and functional interaction of the extracellular domain of human GABA(B) receptor GBR2. Nat Neurosci 15:970-978Golebiewska U, Johnston JM, Devi L, Filizola M, and Scarlata S (2011) Differential response to morphine of the oligomeric state of m-opioid in the presence of d-opioid receptors. Biochemistry 50:2829-2837.
38. Gomes I, Ijzerman AP, Ye K, Maillet EL, and Devi LA (2011) G protein-coupled receptor heteromerization: a role in allosteric modulation of ligand binding. Mol Pharmacol 79:1044-1052.
39. González S, Rangel-Barajas C, Peper M, Lorenzo R, Moreno E, Ciruela F, Borycz J, Ortiz J, Lluís C, and Franco R et al. (2012) Dopamine D4 receptor, but not the ADHD-Associated D4.7 variant, forms functional heteromers with the dopamine D2S receptor in the brain. Mol Psychiatry 17:650-662.
40. González-Maeso J, Ang RL, Yuen T, Chan P, Weisstaub NV, López-Giménez JF, Zhou M, Okawa Y, Callado LF, and Milligan G et al. (2008) Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature 452:93-97.
41. González-Maeso J, Weisstaub NV, Zhou M, Chan P, Ivic L, Ang R, Lira A, Bradley-Moore M, Ge Y, and Zhou Q et al. (2007) Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior. Neuron 53: 439-452.
42. Granier S, Manglik A, Kruse AC, Kobilka TS, Thian FS, Weis WI, and Kobilka BK (2012) Structure of the d-opioid receptor bound to naltrindole. Nature 485:400-404.
43. Guo W, Urizar E, Kralikova M, Mobarec JC, Shi L, Filizola M, and Javitch JA (2008) Dopamine D2 receptors form higher order oligomers at physiological expression levels. EMBO J 27:2293-2304.
44. Gupta A, Mulder J, Gomes I, Rozenfeld R, Bushlin I, Ong E, Lim M, Maillet E, Junek M, and Cahill CM et al. (2010) Increased abundance of opioid receptor heteromers after chronic morphine administration. Sci Signal 3:ra54.
45. Gurevich VV and Gurevich EV (2008) How and why do GPCRs dimerize? Trends Pharmacol Sci 29:234-240.
46. Han Y, Moreira IS, Urizar E, Weinstein H, and Javitch JA (2009) Allosteric communication between protomers of dopamine class A GPCR dimers modulates activation. Nat Chem Biol 5:688-695.
47. Harding PJ, Attrill H, Boehringer J, Ross S, Wadhams GH, Smith E, Armitage JP, and Watts A (2009) Constitutive dimerization of the G-protein coupled receptor, neurotensin receptor 1, reconstituted into phospholipid bilayers. Biophys J 96: 964-973.
48. Harris GL, Creason MB, Brulte GB, and Herr DR (2012) In vitro and in vivo antagonism of a G protein-coupled receptor (S1P3) with a novel blocking monoclonal antibody. PLoS ONE 7:e35129.
49. Hasbi A, O'Dowd BF, and George SR (2011) Dopamine D1-D2 receptor heteromer signaling pathway in the brain: emerging physiological relevance. Mol Brain 4:26.
50. Hebert TE, Moffett S, Morello JP, Loisel TP, Bichet DG, Barret C, and Bouvier M (1996) A peptide derived from a beta2-Adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem 271:16384-16392.
51. Hern JA, Baig AH, Mashanov GI, Birdsall B, Corrie JE, Lazareno S, Molloy JE, and Birdsall NJ (2010) Formation and dissociation of M1 muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single molecules. Proc Natl Acad Sci USA 107:2693-2698
52. Herrick-Davis K, Grinde E, Harrigan TJ, and Mazurkiewicz JE (2005) Inhibition of serotonin 5-hydroxytryptamine2c receptor function through heterodimerization: receptor dimers bind two molecules of ligand and one G-protein. J Biol Chem 280: 40144-40151.
53. Herrick-Davis K, Grinde E, Lindsley T, Cowan A, and Mazurkiewicz JE (2012) Oligomer size of the serotonin 5-hydroxytryptamine 2C (5-HT2C) receptor revealed by fluorescence correlation spectroscopy with photon counting histogram analysis: evidence for homodimers without monomers or tetramers. J Biol Chem 287: 23604-23614.
54. Herrick-Davis K, Weaver BA, Grinde E, and Mazurkiewicz JE (2006) Serotonin 5-HT2C receptor homodimer biogenesis in the endoplasmic reticulum: real-time visualization with confocal fluorescence resonance energy transfer. J Biol Chem 281:27109-27116.
55. Hu J, Thor D, Zhou Y, Liu T, Wang Y, McMillin SM, Mistry R, Challiss RA, Costanzi S, and Wess J (2012) Structural aspects of M muscarinic acetylcholine receptor dimer formation and activation. FASEB J 26:604-616.
56. James JR, Oliveira MI, Carmo AM, Iaboni A, and Davis SJ (2006) A rigorous experimental framework for detecting protein oligomerization using bioluminescence resonance energy transfer. Nat Methods 3:1001-1006.
57. Jäntti MH, Putula J, Turunen PM, Näsman J, Reijonen S, Lindqvist C, and Kukkonen JP (2013) Autocrine endocannabinoid signaling through CB1 receptors potentiates OX1 orexin receptor signaling. Mol Pharmacol 83:621-632.
58. Johnston JM, Aburi M, Provasi D, Bortolato A, Urizar E, Lambert NA, Javitch JA, and Filizola M (2011) Making structural sense of dimerization interfaces of delta opioid receptor homodimers. Biochemistry 50:1682-1690.
59. Johnston JM, Wang H, Provasi D, and Filizola M (2012) Assessing the relative stability of dimer interfaces in g protein-coupled receptors. PLOS Comput Biol 8: e1002649.
60. Kabli N, Martin N, Fan T, Nguyen T, Hasbi A, Balboni G, O'Dowd BF, and George SR (2010) Agonists at the d-opioid receptor modify the binding of m-receptor agonists to the m-d receptor hetero-oligomer. Br J Pharmacol 161:1122-1136.
61. Kasai RS, Suzuki KG, Prossnitz ER, Koyama-Honda I, Nakada C, Fujiwara TK, and Kusumi A (2011) Full characterization of GPCR monomer-dimer dynamic equilibrium by single molecule imaging. J Cell Biol 192:463-480.
62. Kern A, Albarran-Zeckler R, Walsh HE, and Smith RG (2012) Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism. Neuron 73:317-332.
63. Kniazeff J, Prézeau L, Rondard P, Pin JP, and Goudet C (2011) Dimers and beyond: The functional puzzles of class C GPCRs. Pharmacol Ther 130:9-25.
64. Kobayashi H, Ogawa K, Yao R, Lichtarge O, and Bouvier M (2009) Functional rescue of beta-Adrenoceptor dimerization and trafficking by pharmacological chaperones. Traffic 10:1019-1033.
65. Kuszak AJ, Pitchiaya S, Anand JP, Mosberg HI, Walter NG, and Sunahara RK (2009) Purification and functional reconstitution of monomeric mu-opioid receptors: allosteric modulation of agonist binding by Gi2. J Biol Chem 284: 26732-26741.
66. Lan TH, Kuravi S, and Lambert NA (2011) Internalization dissociates b2-Adrenergic receptors. PLoS ONE 6:e17361.
67. Larsson K, Hofström C, Lindskog C, Hansson M, Angelidou P, Hökfelt T, Uhlén M, Wernérus H, Gräslund T, and Hober S (2011) Novel antigen design for the generation of antibodies to G-protein-coupled receptors. J Immunol Methods 370: 14-23.
68. Leskelä TT, Lackman JJ, Vierimaa MM, Kobayashi H, Bouvier M, and Petäjä-Repo UE (2012) Cys-27 variant of human d-opioid receptor modulates maturation and cell surface delivery of Phe-27 variant via heteromerization. J Biol Chem 287: 5008-5020.
69. Liu XY, Liu ZC, Sun YG, Ross M, Kim S, Tsai FF, Li QF, Jeffry J, Kim JY, and Loh HH et al. (2011) Unidirectional cross-Activation of GRPR by MOR1D uncouples itch and analgesia induced by opioids. Cell 147:447-458
70. Lopez-Gimenez JF, Canals M, Pediani JD, and Milligan G (2007) The alpha1badrenoceptor exists as a higher-order oligomer: effective oligomerization is required for receptor maturation, surface delivery, and function. Mol Pharmacol 71: 1015-1029.
71. Ukasiewicz S, Faron-Górecka A, Dobrucki J, Polit A, and Dziedzicka-Wasylewska M (2009) Studies on the role of the receptor protein motifs possibly involved in electrostatic interactions on the dopamine D1 and D2 receptor oligomerization. FEBS J 276:760-775.
72. Ma AW, Redka DS, Pisterzi LF, Angers S, and Wells JW (2007) Recovery of oligomers and cooperativity when monomers of the M2 muscarinic cholinergic receptor are reconstituted into phospholipid vesicles. Biochemistry 46:7907-7927.
73. Maggio R and Millan MJ (2010) Dopamine D2-D3 receptor heteromers: pharmacological properties and therapeutic significance. Curr Opin Pharmacol 10:100-107.
74. Manglik A, Kruse AC, Kobilka TS, Thian FS, Mathiesen JM, Sunahara RK, Pardo L, Weis WI, Kobilka BK, and Granier S (2012) Crystal structure of the m-opioid receptor bound to a morphinan antagonist. Nature 485:321-326.
75. Marcellino D, Ferré S, Casadó V, Cortés A, Le Foll B, Mazzola C, Drago F, Saur O, Stark H, and Soriano A et al. (2008) Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum. J Biol Chem 283:26016-26025.
76. Marquer C, Fruchart-Gaillard C, Letellier G, Marcon E, Mourier G, Zinn-Justin S, Ménez A, Servent D, and Gilquin B (2011) Structural model of ligand-G proteincoupled receptor (GPCR) complex based on experimental double mutant cycle data: MT7 snake toxin bound to dimeric hM1 muscarinic receptor. J Biol Chem 286: 31661-31675.
77. Maurel D, Comps-Agrar L, Brock C, Rives ML, Bourrier E, Ayoub MA, Bazin H, Tinel N, Durroux T, and Prézeau L et al. (2008) Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization. Nat Methods 5:561-567.
78. Maurice P, Kamal M, and Jockers R (2011) Asymmetry of GPCR oligomers supports their functional relevance. Trends Pharmacol Sci 32:514-520.
79. May LT, Bridge LJ, Stoddart LA, Briddon SJ, and Hill SJ (2011) Allosteric interactions across native adenosine-A3 receptor homodimers: quantification using single-cell ligand-binding kinetics. FASEB J 25:3465-3476.
80. Milligan G (2004) G protein-coupled receptor dimerization: function and ligand pharmacology. Mol Pharmacol 66:1-7.
81. Milligan G (2008) A day in the life of a G protein-coupled receptor: the contribution to function of G protein-coupled receptor dimerization. Br J Pharmacol 153 (Suppl 1): S216-S229.
82. Milligan G and Bouvier M (2005) Methods to monitor the quaternary structure of G protein-coupled receptors. FEBS J 272:2914-2925.
83. Milligan G and Smith NJ (2007) Allosteric modulation of heterodimeric G-proteincoupled receptors. Trends Pharmacol Sci 28:615-620.
84. Molinaro G, Traficante A, Riozzi B, Di Menna L, Curto M, Pallottino S, Nicoletti F, Bruno V, and Battaglia G (2009) Activation of mGlu2/3 metabotropic glutamate receptors negatively regulates the stimulation of inositol phospholipid hydrolysis mediated by 5-hydroxytryptamine2A serotonin receptors in the frontal cortex of living mice. Mol Pharmacol 76:379-387.
85. Moreno E, Hoffmann H, Gonzalez-Sepúlveda M, Navarro G, Casadó V, Cortés A, Mallol J, Vignes M, McCormick PJ, and Canela EI et al. (2011a) Dopamine D1-histamine H3 receptor heteromers provide a selective link to MAPK signaling in GABAergic neurons of the direct striatal pathway. J Biol Chem 286:5846-5854.
86. Moreno JL, Holloway T, Albizu L, Sealfon SC, and González-Maeso J (2011b) Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists. Neurosci Lett 493:76-79.
87. Moreno JL, Muguruza C, Umali A, Mortillo S, Holloway T, Pilar-Cuéllar F, Mocci G, Seto J, Callado LF, and Neve RL et al. (2012) Identification of three residues essential for 5-hydroxytryptamine 2A-metabotropic glutamate 2 (5-HT2A·mGlu2) receptor heteromerization and its psychoactive behavioral function. J Biol Chem 287:44301-44319.
88. Navarro G, Ferré S, Cordomi A, Moreno E, Mallol J, Casadó V, Cortés A, Hoffmann H, Ortiz J, and Canela EI et al. (2010) Interactions between intracellular domains as key determinants of the quaternary structure and function of receptor heteromers. J Biol Chem 285:27346-27359.
89. Ng J, Rashid AJ, So CH, O'Dowd BF, and George SR (2010) Activation of calcium/calmodulin-dependent protein kinase IIalpha in the striatum by the heteromeric D1-D2 dopamine receptor complex. Neuroscience 165:535-541.
90. O'Dowd BF, Ji X, Nguyen T, and George SR (2012a) Two amino acids in each of D1 and D2 dopamine receptor cytoplasmic regions are involved in D1-D2 heteromer formation. Biochem Biophys Res Commun 417:23-28
91. O'Dowd BF, Ji X, O'Dowd PB, Nguyen T, and George SR (2012b) Disruption of the mu-delta opioid receptor heteromer. Biochem Biophys Res Commun 422: 556-560.
92. Palmer RK (2007) The pharmacology and signaling of bitter, sweet, and umami taste sensing. Mol Interv 7:87-98
93. Park PS, Sum CS, Pawagi AB, and Wells JW (2002) Cooperativity and oligomeric status of cardiac muscarinic cholinergic receptors. Biochemistry 41:5588-5604.
94. Patowary S, Alvarez-Curto E, Xu T-R, Holz JD, Oliver JA, Milligan G, and Raicu V (2013) The muscarinic M3 acetylcholine receptor exists as two differently sized complexes at the plasma membrane. Biochem J 452:303-312.
95. Pei L, Li S, Wang M, Diwan M, Anisman H, Fletcher PJ, Nobrega JN, and Liu F (2010) Uncoupling the dopamine D1-D2 receptor complex exerts antidepressantlike effects. Nat Med 16:1393-1395.
96. Pellissier LP, Barthet G, Gaven F, Cassier E, Trinquet E, Pin JP, Marin P, Dumuis A, Bockaert J, and Banères JL et al. (2011) G protein activation by serotonin type 4 receptor dimers: evidence that turning on two protomers is more efficient. J Biol Chem 286:9985-9997.
97. Perreault ML, O'Dowd BF, and George SR (2011) Dopamine receptor homooligomers and heterooligomers in schizophrenia. CNS Neurosci Ther 17:52-57.
98. Pétrin D and Hébert TE (2012) The functional size of GPCRs -monomers, dimers or tetramers? Subcell Biochem 63:67-81.
99. Pidasheva S, Grant M, Canaff L, Ercan O, Kumar U, and Hendy GN (2006) Calciumsensing receptor dimerizes in the endoplasmic reticulum: biochemical and biophysical characterization of CASR mutants retained intracellularly. Hum Mol Genet 15:2200-2209.
100. Pin JP, Comps-Agrar L, Maurel D, Monnier C, Rives ML, Trinquet E, Kniazeff J, Rondard P, and Prézeau L (2009) G-protein-coupled receptor oligomers: two or more for what? Lessons from mGlu and GABAB receptors. J Physiol 587: 5337-5344.
101. Pin JP, Neubig R, Bouvier M, Devi L, Filizola M, Javitch JA, Lohse MJ, Milligan G, Palczewski K, and Parmentier M et al. (2007) International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimers. Pharmacol Rev 59: 5-13.
102. Pisterzi LF, Jansma DB, Georgiou J, Woodside MJ, Chou JT, Angers S, Raicu V, and Wells JW (2010) Oligomeric size of the m2 muscarinic receptor in live cells as determined by quantitative fluorescence resonance energy transfer. J Biol Chem 285:16723-16738
103. Pou C, Mannoury la Cour C, Stoddart LA, Millan MJ, and Milligan G (2012) Functional homomers and heteromers of dopamine D2L and D3 receptors co-exist at the cell surface. J Biol Chem 287:8864-8878Provasi D, Johnston JM, and Filizola M (2010) Lessons from free energy simulations of delta-opioid receptor homodimers involving the fourth transmembrane helix. Biochemistry 49:6771-6776.
104. Rasmussen SG, DeVree BT, Zou Y, Kruse AC, Chung KY, Kobilka TS, Thian FS, Chae PS, Pardon E, and Calinski D et al. (2011) Crystal structure of the b2 adrenergic receptor-Gs protein complex. Nature 477:549-555.
105. Rios C, Gomes I, and Devi LA (2006) mu opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis. Br J Pharmacol 148:387-395.
106. Rivero-Müller A, Chou YY, Ji I, Lajic S, Hanyaloglu AC, Jonas K, Rahman N, Ji TH, and Huhtaniemi I (2010) Rescue of defective G protein-coupled receptor function in vivo by intermolecular cooperation. Proc Natl Acad Sci USA 107: 2319-2324.
107. Rosenbaum DM, Rasmussen SG, and Kobilka BK (2009) The structure and function of G-protein-coupled receptors. Nature 459:356-363.
108. Rovira X, Vivó M, Serra J, Roche D, Strange PG, and Giraldo J (2009) Modelling the interdependence between the stoichiometry of receptor oligomerization and ligand binding for a coexisting dimer/tetramer receptor system. Br J Pharmacol 156: 28-35.
109. Rozenfeld R, Bushlin I, Gomes I, Tzavaras N, Gupta A, Neves S, Battini L, Gusella GL, Lachmann A, and Ma'ayan A et al. (2012) Receptor heteromerization expands the repertoire of cannabinoid signaling in rodent neurons. PLoS ONE 7:e29239.
110. Rozenfeld R, Gupta A, Gagnidze K, Lim MP, Gomes I, Lee-Ramos D, Nieto N, and Devi LA (2011) AT1R-CBR heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II. EMBO J 30:2350-2363.
111. Salahpour A, Angers S, Mercier JF, Lagacé M, Marullo S, and Bouvier M (2004) Homodimerization of the beta2-Adrenergic receptor as a prerequisite for cell surface targeting. J Biol Chem 279:33390-33397.
112. Salahpour A and Masri B (2007) Experimental challenge to a 'rigorous' BRET analysis of GPCR oligomerization. Nat Methods 4:599-600, author reply 601.
113. Salanga CL, O'Hayre M, and Handel T (2009) Modulation of chemokine receptor activity through dimerization and crosstalk. Cell Mol Life Sci 66:1370-1386.
114. Sartania N, Appelbe S, Pediani JD, and Milligan G (2007) Agonist occupancy of a single monomeric element is sufficient to cause internalization of the dimeric beta2-Adrenoceptor. Cell Signal 19:1928-1938
115. Scherrer G, Imamachi N, Cao YQ, Contet C, Mennicken F, O'Donnell D, Kieffer BL, and Basbaum AI (2009) Dissociation of the opioid receptor mechanisms that control mechanical and heat pain. Cell 137:1148-1159.
116. Smith NJ and Milligan G (2010) Allostery at G protein-coupled receptor homo-And heteromers: uncharted pharmacological landscapes. Pharmacol Rev 62:701-725.
117. Sohy D, Parmentier M, and Springael JY (2007) Allosteric transinhibition by specific antagonists in CCR2/CXCR4 heterodimers. J Biol Chem 282:30062-30069.
118. Sohy D, Yano H, de Nadai P, Urizar E, Guillabert A, Javitch JA, Parmentier M, and Springael JY (2009) Hetero-oligomerization of CCR2, CCR5, and CXCR4 and the protean effects of "selective" antagonists. J Biol Chem 284:31270-31279.
119. Szalai B, Barkai L, Turu G, Szidonya L, Várnai P, and Hunyady L (2012) Allosteric interactions within the AT angiotensin receptor homodimer: role of the conserved DRY motif. Biochem Pharmacol 84:477-485.
120. Thelen M, Muñoz LM, Rodríguez-Frade JM, and Mellado M (2010) Chemokine receptor oligomerization: functional considerations. Curr Opin Pharmacol 10:38-43.
121. Trifilieff P, Rives ML, Urizar E, Piskorowski RA, Vishwasrao HD, Castrillon J, Schmauss C, Slättman M, Gullberg M, and Javitch JA (2011) Detection of antigen interactions ex vivo by proximity ligation assay: endogenous dopamine D2-Adenosine A2A receptor complexes in the striatum. Biotechniques 51:111-118
122. Uddin MS, Kim H, Deyo A, Naider F, and Becker JM (2012) Identification of residues involved in homodimer formation located within a b-strand region of the N-terminus of a Yeast G protein-coupled receptor. J Recept Signal Transduct Res 32:65-75.
123. Vilardaga JP, Nikolaev VO, Lorenz K, Ferrandon S, Zhuang Z, and Lohse MJ (2008) Conformational cross-talk between alpha2A-Adrenergic and mu-opioid receptors controls cell signaling. Nat Chem Biol 4:126-131.
124. Wang HX and Konopka JB (2009) Identification of amino acids at two dimer interface regions of the alpha-factor receptor (Ste2). Biochemistry 48:7132-7139.
125. Wang J and Norcross M (2008) Dimerization of chemokine receptors in living cells: key to receptor function and novel targets for therapy. Drug Discov Today 13:625-632.
126. Wang M, Pei L, Fletcher PJ, Kapur S, Seeman P, and Liu F (2010) Schizophrenia, amphetamine-induced sensitized state and acute amphetamine exposure all show a common alteration: increased dopamine D2 receptor dimerization. Mol Brain 3:25.
127. Ward RJ, Pediani JD, and Milligan G (2011) Heteromultimerization of cannabinoid CB(1) receptor and orexin OX(1) receptor generates a unique complex in which both protomers are regulated by orexin A. J Biol Chem 286:37414-37428
128. Whorton MR, Bokoch MP, Rasmussen SG, Huang B, Zare RN, Kobilka B, and Sunahara RK (2007) A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein. Proc Natl Acad Sci USA 104:7682-7687.
129. Whorton MR, Jastrzebska B, Park PS, Fotiadis D, Engel A, Palczewski K, and Sunahara RK (2008) Efficient coupling of transducin to monomeric rhodopsin in a phospholipid bilayer. J Biol Chem 283:4387-4394.
130. Wilson S, Wilkinson G, and Milligan G (2005) The CXCR1 and CXCR2 receptors form constitutive homo-And heterodimers selectively and with equal apparent affinities. J Biol Chem 280:28663-28674.
131. Wu B, Chien EY, Mol CD, Fenalti G, Liu W, Katritch V, Abagyan R, Brooun A, Wells P, and Bi FC et al. (2010) Structures of the CXCR4 chemokine GPCR with smallmolecule and cyclic peptide antagonists. Science 330:1066-1071.
132. Wu H, Wacker D, Mileni M, Katritch V, Han GW, Vardy E, Liu W, Thompson AA, Huang XP, and Carroll FI et al. (2012) Structure of the human k-opioid receptor in complex with JDTic. Nature 485:327-332.
133. Xu T-R, Ward RJ, Pediani JD, and Milligan G (2011) The orexin OX(1) receptor exists predominantly as a homodimer in the basal state: potential regulation of receptor organization by both agonist and antagonist ligands. Biochem J 439:171-183.
134. Xu T-R, Ward RJ, Pediani JD, and Milligan G (2012) Intramolecular fluorescence resonance energy transfer (FRET) sensors of the orexin OX1 and OX2 receptors identify slow kinetics of agonist activation. J Biol Chem 287:14937-14949.
135. Zhang M, Guan R, and Segaloff DL (2012) Revisiting and questioning functional rescue between dimerized LH receptor mutants. Mol Endocrinol 26:655-668